Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy-Reference-Cited by-同舟云学术

Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy

Published:2015-07 Issue:7 Volume:17 Page:468-474
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Chiefari Eusebio¹,Capula Carmelo²,Vero Ada²,Oliverio Rosa¹,Puccio Luigi²,Liguori Rossella¹,Pullano Vittorio²,Greco Manfredi³,Foti Daniela¹,Tirinato Domenico⁴,Vero Raffaella²,Brunetti Antonio¹

Affiliation:

1. Department of Health Sciences, University “Magna Græcia” of Catanzaro, Catanzaro, Italy.

2. Complex Operative Structure of Endocrinology-Diabetology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.

3. Department of Experimental and Clinical Medicine, University “Magna Græcia” of Catanzaro, Catanzaro, Italy.

4. Diabetologic Unit, Soverato Hospital, Soverato, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2014.0412

Reference29 articles.

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

2. Liraglutide for the Treatment of Type 2 Diabetes

3. Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

4. Review of the Therapeutic Uses of Liraglutide

5. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in type 2 diabetes;Diabetologia;2023-03-10

2. New-onset diabetes in COVID-19: The molecular pathogenesis;BioMedicine;2023-02-22

3. Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care;Journal of Personalized Medicine;2022-03-13

4. Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs;Current Opinion in Pharmacology;2021-10

5. Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes;Journal of Clinical Medicine;2021-03-02